awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q41145898-4D9F64FD-B1CF-445D-B250-BCFDC0658B3B
Q41145898-4D9F64FD-B1CF-445D-B250-BCFDC0658B3B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41145898-4D9F64FD-B1CF-445D-B250-BCFDC0658B3B
Progression-free survival of first-line treatment with molecular-targeted therapy may be a meaningful intermediate endpoint for overall survival in patients with metastatic renal cell carcinoma.
P2860
Q41145898-4D9F64FD-B1CF-445D-B250-BCFDC0658B3B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41145898-4D9F64FD-B1CF-445D-B250-BCFDC0658B3B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2a5cd4f3a041607d793046592227fd3d5bfba7b3
P2860
Immunotherapy for advanced renal cell cancer